This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Prostate Cancer
  • /
  • Degarelix, a novel GnRH antagonist, causes minimal...

Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an ex vivo model of human skin samples.

Read time: 1 mins
Published:1st Oct 2010
Author: Koechling W, Hjortkjaer R, Tankó LB.
Availability: Free full text
Ref.:Br J Clin Pharmacol. 2010 Oct;70(4):580-7.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest